IronBridge Capital Management’s Standard BioTools LAB Stock Holding History

IronBridge Capital Management’s Portfolio LAB Stock Details LAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-149,133	Closed	-$3.61M	–	186
2015 Q2	$3.61M	Buy	149,133 +18,000	+14%	+$568K	0.11%	142
2015 Q1	$5.52M	Sell	131,133 -11,860	-8%	-$469K	0.16%	133
2014 Q4	$4.82M	Buy	142,993 +29,830	+26%	+$845K	0.13%	152
2014 Q3	$2.77M	Buy	113,163 +2,240	+2%	+$63K	0.07%	167
2014 Q2	$3.26M	Buy	110,923 +56,883	+105%	+$1.82M	0.08%	165
2014 Q1	$2.38M	Buy	+54,040	New	+$2.38M	0.05%	170

Other funds holding LAB

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

SCM

Scopia Capital Management New York $112M AUM 48.41% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EAM

EverPoint Asset Management Stamford, Connecticut $5.38B AUM 21.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

IronBridge Capital Management's LAB Position: Q3 2015 in Review

IronBridge Capital Management sold out of Standard BioTools (LAB) in Q3 2015, closing a stake of 149,133 shares — an estimated $3.61M sold.

IronBridge Capital Management first reported a position in LAB in Q1 2014 and held it in 6 quarters. The position peaked at $5.52M in Q1 2015. 109 funds tracked by Wall St. Rank hold LAB as of Q3 2015.

IronBridge Capital Management reported no remaining Standard BioTools position as of Q3 2015 after selling out during the quarter.
IronBridge Capital Management sold 149,133 Standard BioTools shares in Q3 2015, an estimated $3.61M.
IronBridge Capital Management first reported a position in Standard BioTools in Q1 2014 and held it in 6 quarters.
IronBridge Capital Management's Standard BioTools position peaked at $5.52M in Q1 2015.
109 funds tracked by Wall St. Rank held Standard BioTools as of Q3 2015.

Based on IronBridge Capital Management's 13F filing for Q3 2015, filed 10 Nov 2015.